1 OMEPRAZOLE | 660 of 6710 | 3330 prescriptions Less than 1% of all prescriptions | 2320 | 750 patients 11% of all patients | 560 patients 8% of all patients | |
2 PANTOPRAZOLE SODIUM | 640 of 6360 | 3140 prescriptions Less than 1% of all prescriptions | 1950 | 690 patients 10% of all patients | 520 patients 8% of all patients | |
3 RANITIDINE HCL | 200 of 4330 | 2190 prescriptions Less than 1% of all prescriptions | 1180 | 510 patients 7% of all patients | 330 patients 5% of all patients | |
4 FAMOTIDINE | 200 of 2860 | 1590 prescriptions Less than 1% of all prescriptions | 950 | 340 patients 5% of all patients | 220 patients 3% of all patients | |
5 LANSOPRAZOLE | 60 of 2200 | 840 prescriptions Less than 1% of all prescriptions | 500 | 220 patients 3% of all patients | < 11 | |
6 DEXILANT (DEXLANSOPRAZOLE) | 120 of 3170 | 1070 prescriptions Less than 1% of all prescriptions | 630 | 220 patients 3% of all patients | 110 patients 2% of all patients | |
7 ESOMEPRAZOLE MAGNESIUM | 210 of 3620 | 750 prescriptions Less than 1% of all prescriptions | 590 | 230 patients 3% of all patients | < 11 | |
8 POLYETHYLENE GLYCOL 3350 | 360 of 3130 | 790 prescriptions Less than 1% of all prescriptions | 470 | 210 patients 3% of all patients | < 11 | |
9 NEXIUM (ESOMEPRAZOLE MAGNESIUM) | 20 of 810 | 490 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
10 ENTYVIO (VEDOLIZUMAB) | 10 of 80 | 270 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
11 REMICADE (INFLIXIMAB) | 10 of 60 | 290 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 GLYCOPYRROLATE | 40 of 150 | 400 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
13 METOCLOPRAMIDE HCL | 230 of 1460 | 410 prescriptions Less than 1% of all prescriptions | 220 | 150 patients 2% of all patients | < 11 | |
14 LINZESS (LINACLOTIDE) | 610 of 3720 | 330 prescriptions Less than 1% of all prescriptions | 200 | 140 patients 2% of all patients | < 11 | |
15 MERCAPTOPURINE | 250 of 770 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 STELARA (USTEKINUMAB) | 80 of 120 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 DICYCLOMINE HCL | 1010 of 4090 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 SUPREP (SODIUM, POTASSIUM,MAG SULFATES) | 150 of 3100 | 2750 prescriptions Less than 1% of all prescriptions | 2300 | 2750 patients 40% of all patients | 2300 patients 34% of all patients | |
19 AZATHIOPRINE | 330 of 1840 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 URSODIOL | 600 of 2030 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 XIFAXAN (RIFAXIMIN) | 340 of 1510 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
22 PROCHLORPERAZINE MALEATE | 20 of 270 | 3280 prescriptions Less than 1% of all prescriptions | 2490 | 3190 patients 47% of all patients | 2450 patients 36% of all patients | |
23 CARAFATE (SUCRALFATE) | 280 of 1090 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 AMITIZA (LUBIPROSTONE) | 330 of 1720 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 CREON (LIPASE/PROTEASE/AMYLASE) | 350 of 1460 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 OCALIVA (OBETICHOLIC ACID) | 110 of 240 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
27 LACTULOSE | 290 of 1160 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 LEVOFLOXACIN | 60 of 80 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | A |
29 PEG 3350-ELECTROLYTE (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 520 of 1490 | 300 prescriptions Less than 1% of all prescriptions | 180 | 300 patients 4% of all patients | 180 patients 3% of all patients | |
30 GAVILYTE-N (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 520 of 1620 | 350 prescriptions Less than 1% of all prescriptions | 160 | 330 patients 5% of all patients | 160 patients 2% of all patients | |